Abstract
Mycolic acids are exceptionally long-chain fatty acids that are major and specific lipid components of the cell envelope of members of the Corynebacteriales order, which includes the causative agents of both tuberculosis and leprosy. These acids participate to the composition of the recently discovered “outer membrane,” a component unexpected for these Gram-positive microorganisms. Many proteins involved in mycolic acid biosynthesis and transport are essential for the mycobacterial survival and represent both validated targets and highly relevant candidates for the development of novel antimycobacterial agents, in the alarming context of multidrug-resistant tuberculosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Alahari A, Trivelli X, Guerardel Y, Dover LG, Besra GS, Sacchettini JC, Reynolds RC, Coxon GD, Kremer L (2007) Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria. PLoS One 2:e1343
Asselineau C, Asselineau J (1966) Stéréochimie de l’acide corynomycolique. Bull Soc Chim Fr 6:1992–1999
Asselineau J, Lederer E (1950) Structure of the mycolic acids of mycobacteria. Nature 166:782–783
Asselineau C, Tocanne G, Tocanne JF (1970a) Stéréochimie des acides mycoliques. Bull Soc Chim Fr 4:1455–1459
Asselineau CP, Lacave CS, Montrozier HL, Prome JC (1970b) Structural relations between unsaturated mycolic acids and short-chain unsaturated acids synthesized by Mycobacterium phlei. Metabolic implications. Eur J Biochem 14:406–410
Asselineau C, Asselineau J, Laneelle G, Laneelle MA (2002) The biosynthesis of mycolic acids by mycobacteria: current and alternative hypotheses. Prog Lipid Res 41:501–523
Av-Gay Y, Everett M (2000) The eukaryotic-like Ser/Thr protein kinases of Mycobacterium tuberculosis. Trends Microbiol 8:238–244
Banerjee A, Dubnau E, Quemard A, Balasubramanian V, Um KS, Wilson T, Collins D, de Lisle G, Jacobs WR Jr (1994) inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227–230
Bardou F, Quemard A, Dupont MA, Horn C, Marchal G, Daffe M (1996) Effects of isoniazid on ultrastructure of Mycobacterium aurum and Mycobacterium tuberculosis and on production of secreted proteins. Antimicrob Agents Chemother 40:2459–2467
Basso LA, Zheng R, Musser JM, Jacobs WR Jr, Blanchard JS (1998) Mechanisms of isoniazid resistance in Mycobacterium tuberculosis: enzymatic characterization of enoyl reductase mutants identified in isoniazid-resistant clinical isolates. J Infect Dis 178:769–775
Bazet Lyonnet B, Diacovich L, Cabruja M, Bardou F, Quemard A, Gago G, Gramajo H (2014) Pleiotropic effect of AccD5 and AccE5 depletion in acyl-coenzyme A carboxylase activity and in lipid biosynthesis in mycobacteria. PLoS One 6:e99853
Belardinelli JM, Morbidoni HR (2012) Mutations in the essential FAS II beta-hydroxyacyl ACP dehydratase complex confer resistance to thiacetazone in Mycobacterium tuberculosis and Mycobacterium kansasii. Mol Microbiol 86:568–579
Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ, Besra GS (1997) Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 276:1420–1422
Bergeret F, Gavalda S, Chalut C, Malaga W, Quemard A, Pedelacq JD, Daffe M, Guilhot C, Mourey L, Bon C (2012) Biochemical and structural study of the atypical acyltransferase domain from the mycobacterial polyketide synthase Pks13. J Biol Chem 287:33675–33690
Bhatt A, Kremer L, Dai AZ, Sacchettini JC, Jacobs WR Jr (2005) Conditional depletion of KasA, a key enzyme of mycolic acid biosynthesis, leads to mycobacterial cell lysis. J Bacteriol 187:7596–7606
Bhatt A, Molle V, Besra GS, Jacobs WR Jr, Kremer L (2007a) The Mycobacterium tuberculosis FAS-II condensing enzymes: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development. Mol Microbiol 64:1442–1454
Bhatt A, Fujiwara N, Bhatt K, Gurcha SS, Kremer L, Chen B, Chan J, Porcelli SA, Kobayashi K, Besra GS, Jacobs WR Jr (2007b) Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice. Proc Natl Acad Sci U S A 104:5157–5162
Bhatt A, Brown AK, Singh A, Minnikin DE, Besra GS (2008) Loss of a mycobacterial gene encoding a reductase leads to an altered cell wall containing beta-oxo-mycolic acid analogs and accumulation of ketones. Chem Biol 15:930–939
Biswas RK, Dutta D, Tripathi A, Feng Y, Banerjee M, Singh BN (2013) Identification and characterization of Rv0494: a fatty acid-responsive protein of the GntR/FadR family from Mycobacterium tuberculosis. Microbiology 159:913–923
Bloch K (1969) Enzymatic synthesis of monounsaturated fatty acids. Acc Chem Res 2:193–202
Bloch K (1977) Control mechanisms for fatty acid synthesis in Mycobacterium smegmatis. Adv Enzymol Relat Areas Mol Biol 45:1–84
Bloch K, Vance D (1977) Control mechanisms in the synthesis of saturated fatty acids. Annu Rev Biochem 46:263–298
Boehringer D, Ban N, Leibundgut M (2013) 7.5-A cryo-em structure of the mycobacterial fatty acid synthase. J Mol Biol 425:841–849
Bordet C, Michel G (1969) Structure and biogenesis of high molecular weight lipids from Nocardia asteroides. Bull Soc Chim Biol (Paris) 51:527–548
Brown JR, North EJ, Hurdle JG, Morisseau C, Scarborough JS, Sun D, Kordulakova J, Scherman MS, Jones V, Grzegorzewicz A, Crew RM, Jackson M, McNeil MR, Lee RE (2011) The structure-activity relationship of urea derivatives as anti-tuberculosis agents. Bioorg Med Chem 19:5585–5595
Cantaloube S, Veyron-Churlet R, Haddache N, Daffe M, Zerbib D (2011) The Mycobacterium tuberculosis FAS-II dehydratases and methyltransferases define the specificity of the mycolic acid elongation complexes. PLoS One 6:e29564
Cantrell SA, Leavell MD, Marjanovic O, Iavarone AT, Leary JA, Riley LW (2013) Free mycolic acid accumulation in the cell wall of the mce1 operon mutant strain of Mycobacterium tuberculosis. J Microbiol 51:619–626
Carel C, Nukdee K, Cantaloube S, Bonne M, Diagne CT, Laval F, Daffe M, Zerbib D (2014) Mycobacterium tuberculosis proteins involved in mycolic acid synthesis and transport localize dynamically to the old growing pole and septum. PLoS One 9:e97148
Carrere-Kremer S, Blaise M, Singh VK, Alibaud L, Tuaillon E, Halloum I, van de Weerd R, Guerardel Y, Drancourt M, Takiff H, Geurtsen J, Kremer L (2015) A new dehydratase conferring innate resistance to thiacetazone and intra-amoebal survival of Mycobacterium smegmatis. Mol Microbiol 96:1085–1102
Carroll P, Faray-Kele MC, Parish T (2011) Identifying vulnerable pathways in Mycobacterium tuberculosis by using a knockdown approach. Appl Environ Microbiol 77:5040–5043
Ciccarelli L, Connell SR, Enderle M, Mills DJ, Vonck J, Grininger M (2013) Structure and conformational variability of the Mycobacterium tuberculosis fatty acid synthase multienzyme complex. Structure 21:1251–1257
Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Barrell BG (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537–544
Corrales RM, Molle V, Leiba J, Mourey L, de Chastellier C, Kremer L (2012) Phosphorylation of mycobacterial PcaA inhibits mycolic acid cyclopropanation: consequences for intracellular survival and for phagosome maturation block. J Biol Chem 287:26187–26199
Daffé M, Draper P (1998) The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 39:131–203
Daffé M, Laneelle MA, Asselineau C, Levy-Frebault V, David H (1983) Taxonomic value of mycobacterial fatty acids: proposal for a method of analysis. Ann Microbiol (Paris) 134B:241–256
De Sousa-D’Auria C, Kacem R, Puech V, Tropis M, Leblon G, Houssin C, Daffe M (2003) New insights into the biogenesis of the cell envelope of corynebacteria: identification and functional characterization of five new mycoloyltransferase genes in Corynebacterium glutamicum. FEMS Microbiol Lett 224:35–44
DeBarber AE, Mdluli K, Bosman M, Bekker LG, Barry CE 3rd (2000) Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 97:9677–9682
Dessen A, Quemard A, Blanchard JS, Jacobs WR Jr, Sacchettini JC (1995) Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science 267:1638–1641
Dinadayala P, Laval F, Raynaud C, Lemassu A, Laneelle MA, Laneelle G, Daffe M (2003) Tracking the putative biosynthetic precursors of oxygenated mycolates of Mycobacterium tuberculosis. Structural analysis of fatty acids of a mutant strain deviod of methoxy- and ketomycolates. J Biol Chem 278:7310–7319
Douglas JD, Senior SJ, Morehouse C, Phetsukiri B, Campbell IB, Besra GS, Minnikin DE (2002) Analogues of thiolactomycin: potential drugs with enhanced anti-mycobacterial activity. Microbiology 148:3101–3109
Dover LG, Alahari A, Gratraud P, Gomes JM, Bhowruth V, Reynolds RC, Besra GS, Kremer L (2007) EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets. Antimicrob Agents Chemother 51:1055–1063
Draper P (1998) The outer parts of the mycobacterial envelope as permeability barriers. Front Biosci 3:D1253–D1261
Dubnau E, Laneelle MA, Soares S, Benichou A, Vaz T, Prome D, Prome JC, Daffe M, Quemard A (1997) Mycobacterium bovis BCG genes involved in the biosynthesis of cyclopropyl keto- and hydroxy-mycolic acids. Mol Microbiol 23:313–322
Dubnau E, Marrakchi H, Smith I, Daffe M, Quemard A (1998) Mutations in the cmaB gene are responsible for the absence of methoxymycolic acid in Mycobacterium bovis BCG Pasteur. Mol Microbiol 29:1526–1528
Dubnau E, Chan J, Raynaud C, Mohan VP, Laneelle MA, Yu K, Quemard A, Smith I, Daffe M (2000) Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol Microbiol 36:630–637
Dupont C, Viljoen A, Dubar F, Blaise M, Bernut A, Pawlik A, Bouchier C, Brosch R, Guerardel Y, Lelievre J, Ballell L, Herrmann JL, Biot C, Kremer L (2016) A new piperidinol derivative targeting mycolic acid transport in Mycobacterium abscessus. Mol Microbiol 101:515–529
Etemadi AH (1967) Structural and biogenetic correlations of mycolic acids in relation to the phylogenesis of various genera of Actinomycetales. Bull Soc Chim Biol (Paris) 49:695–706
Etemadi AH, Gasche J (1965) On the biogenetic origin of 2-eicosanol and 2-octadecanol of Mycobacterium avium. Bull Soc Chim Biol (Paris) 47:2095–2104
Ferrer NL, Gomez AB, Soto CY, Neyrolles O, Gicquel B, Garcia-Del Portillo F, Martin C (2009) Intracellular replication of attenuated Mycobacterium tuberculosis phoP mutant in the absence of host cell cytotoxicity. Microbes Infect 11:115–122
Flipo M, Willand N, Lecat-Guillet N, Hounsou C, Desroses M, Leroux F, Lens Z, Villeret V, Wohlkonig A, Wintjens R, Christophe T, Kyoung Jeon H, Locht C, Brodin P, Baulard AR, Deprez B (2012) Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis. J Med Chem 55:6391–6402
Forrellad MA, McNeil M, Santangelo Mde L, Blanco FC, Garcia E, Klepp LI, Huff J, Niederweis M, Jackson M, Bigi F (2014) Role of the Mce1 transporter in the lipid homeostasis of Mycobacterium tuberculosis. Tuberculosis (Edinb) 94:170–177
Gago G, Kurth D, Diacovich L, Tsai SC, Gramajo H (2006) Biochemical and structural characterization of an essential acyl coenzyme A carboxylase from Mycobacterium tuberculosis. J Bacteriol 188:477–486
Galandrin S, Guillet V, Rane RS, Leger M, Radha N, Eynard N, Das K, Balganesh TS, Mourey L, Daffe M, Marrakchi H (2013) Assay development for identifying inhibitors of the mycobacterial FadD32 activity. J Biomol Screen 18:576–587
Gande R, Gibson KJ, Brown AK, Krumbach K, Dover LG, Sahm H, Shioyama S, Oikawa T, Besra GS, Eggeling L (2004) Acyl-CoA carboxylases (accD2 and accD3), together with a unique polyketide synthase (Cg-pks), are key to mycolic acid biosynthesis in Corynebacterianeae such as Corynebacterium glutamicum and Mycobacterium tuberculosis. J Biol Chem 279:44847–44857
Gannoun-Zaki L, Alibaud L, Kremer L (2013) Point mutations within the fatty acid synthase type II dehydratase components HadA or HadC contribute to isoxyl resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 57:629–632
Gao LY, Laval F, Lawson EH, Groger RK, Woodruff A, Morisaki JH, Cox JS, Daffe M, Brown EJ (2003) Requirement for kasB in Mycobacterium mycolic acid biosynthesis, cell wall impermeability and intracellular survival: implications for therapy. Mol Microbiol 49:1547–1563
Gavalda S, Leger M, van der Rest B, Stella A, Bardou F, Montrozier H, Chalut C, Burlet-Schiltz O, Marrakchi H, Daffe M, Quemard A (2009) The Pks13/FadD32 crosstalk for the biosynthesis of mycolic acids in Mycobacterium tuberculosis. J Biol Chem 284:19255–19264
Gavalda S, Bardou F, Laval F, Bon C, Malaga W, Chalut C, Guilhot C, Mourey L, Daffe M, Quemard A (2014) The polyketide synthase Pks13 catalyzes a novel mechanism of lipid transfer in mycobacteria. Chem Biol 21:1660–1669
Glickman MS (2008) Cording, cord factors, and trehalose dimycolate. In: Daffé M, Reyrat JM (eds) The mycobacterial cell envelope. ASM Press, Washington, DC, pp 63–73
Glickman MS, Cox JS, Jacobs WR Jr (2000) A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol Cell 5:717–727
Glickman MS, Cahill SM, Jacobs WR (2001) The Mycobacterium tuberculosis cmaA2 gene encodes a mycolic acid trans-cyclopropane synthetase. J Biol Chem 276:2228–2233
Goren MB, Brennan PJ (1979) Mycobacterial lipids: chemistry and biological activities. In: Youmans GP (ed) Tuberculosis. The WB Saunders Co, Philadelphia, pp 63–193
Greenstein AE, Grundner C, Echols N, Gay LM, Lombana TN, Miecskowski CA, Pullen KE, Sung PY, Alber T (2005) Structure/function studies of Ser/Thr and Tyr protein phosphorylation in Mycobacterium tuberculosis. J Mol Microbiol Biotechnol 9:167–181
Grzegorzewicz AE, Pham H, Gundi VA, Scherman MS, North EJ, Hess T, Jones V, Gruppo V, Born SE, Kordulakova J, Chavadi SS, Morisseau C, Lenaerts AJ, Lee RE, McNeil MR, Jackson M (2012a) Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane. Nat Chem Biol 8:334–341
Grzegorzewicz AE, Kordulakova J, Jones V, Born SE, Belardinelli JM, Vaquie A, Gundi VA, Madacki J, Slama N, Laval F, Vaubourgeix J, Crew RM, Gicquel B, Daffe M, Morbidoni HR, Brennan PJ, Quemard A, McNeil MR, Jackson M (2012b) A common mechanism of inhibition of the Mycobacterium tuberculosis mycolic acid biosynthetic pathway by isoxyl and thiacetazone. J Biol Chem 287:38434–38441
Grzegorzewicz AE, Eynard N, Quemard A, North EJ, Margolis A, Lindenberger JJ, Jones V, Kordulakova J, Brennan PJ, Lee RE, Ronning DR, McNeil MR, Jackson M (2015) Covalent modification of the FAS-II dehydratase by Isoxyl and Thiacetazone. ACS Infect Dis 1:91–97
Guillet V, Galandrin S, Maveyraud L, Ladeveze S, Mariaule V, Bon C, Eynard N, Daffe M, Marrakchi H, Mourey L (2016) Insight into structure-function relationships and inhibition of the fatty acyl-AMP ligase (FadD32) orthologs from mycobacteria. J Biol Chem 291:7973–7989
Halloum I, Carrere-Kremer S, Blaise M, Viljoen A, Bernut A, Le Moigne V, Vilcheze C, Guerardel Y, Lutfalla G, Herrmann JL, Jacobs WR Jr, Kremer L (2016) Deletion of a dehydratase important for intracellular growth and cording renders rough Mycobacterium abscessus avirulent. Proc Natl Acad Sci U S A 113:E4228–E4237
Hanoulle X, Wieruszeski JM, Rousselot-Pailley P, Landrieu I, Locht C, Lippens G, Baulard AR (2006) Selective intracellular accumulation of the major metabolite issued from the activation of the prodrug ethionamide in mycobacteria. J Antimicrob Chemother 58:768–772
Hoffmann C, Leis A, Niederweis M, Plitzko JM, Engelhardt H (2008) Disclosure of the mycobacterial outer membrane: cryo-electron tomography and vitreous sections reveal the lipid bilayer structure. Proc Natl Acad Sci U S A 105:3963–3967
Hong S, Cheng TY, Layre E, Sweet L, Young DC, Posey JE, Butler WR, Moody DB (2012) Ultralong C100 mycolic acids support the assignment of Segniliparus as a new bacterial genus. PLoS One 7:e39017
Hunter RL, Armitige L, Jagannath C, Actor JK (2009) TB research at UT-Houston – a review of cord factor: new approaches to drugs, vaccines and the pathogenesis of tuberculosis. Tuberculosis (Edinb) 89:S18–S25
Indrigo J, Hunter RL Jr, Actor JK (2002) Influence of trehalose 6,6′-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages. Microbiology 148:1991–1998
Indrigo J, Hunter RL Jr, Actor JK (2003) Cord factor trehalose 6,6′-dimycolate (TDM) mediates trafficking events during mycobacterial infection of murine macrophages. Microbiology 149:2049–2059
Ioerger TR, O’Malley T, Liao R, Guinn KM, Hickey MJ, Mohaideen N, Murphy KC, Boshoff HI, Mizrahi V, Rubin EJ, Sassetti CM, Barry CE 3rd, Sherman DR, Parish T, Sacchettini JC (2013) Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis. PLoS One 8:e75245
Jackson M, Raynaud C, Laneelle MA, Guilhot C, Laurent-Winter C, Ensergueix D, Gicquel B, Daffe M (1999) Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope. Mol Microbiol 31:1573–1587
Jamet S, Quentin Y, Coudray C, Texier P, Laval F, Daffe M, Fichant G, Cam K (2015a) Evolution of mycolic acid biosynthesis genes and their regulation during starvation in Mycobacterium tuberculosis. J Bacteriol 197:3797–3811
Jamet S, Slama N, Domingues J, Laval F, Texier P, Eynard N, Quemard A, Peixoto A, Lemassu A, Daffe M, Cam K (2015b) The non-essential mycolic acid biosynthesis genes hadA and hadC contribute to the physiology and fitness of Mycobacterium smegmatis. PLoS One 10:e0145883
Jarlier V, Nikaido H (1994) Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol Lett 123:11–18
Johnsson K, Shultz PG (1994) Mechanistic studies of the oxidation of isoniazid by the catalase peroxidase from Mycobacterium tuberculosis. J Am Chem Soc 116:7425–7426
Julian E, Roldan M, Sanchez-Chardi A, Astola O, Agusti G, Luquin M (2010) Microscopic cords, a virulence-related characteristic of Mycobacterium tuberculosis, are also present in nonpathogenic mycobacteria. J Bacteriol 192:1751–1760
Kalscheuer R, Weinrick B, Veeraraghavan U, Besra GS, Jacobs WR Jr (2010) Trehalose-recycling ABC transporter LpqY-SugA-SugB-SugC is essential for virulence of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 107:21761–21766
Kapilashrami K, Bommineni GR, Machutta CA, Kim P, Lai CT, Simmerling C, Picart F, Tonge PJ (2013) Thiolactomycin-based beta-ketoacyl-AcpM synthase A (KasA) inhibitors: fragment-based inhibitor discovery using transient one-dimensional nuclear overhauser effect NMR spectroscopy. J Biol Chem 288:6045–6052
Kordulakova J, Janin YL, Liav A, Barilone N, Dos Vultos T, Rauzier J, Brennan PJ, Gicquel B, Jackson M (2007) Isoxyl activation is required for bacteriostatic activity against Mycobacterium tuberculosis. Antimicrob Agents Chemother 51:3824–3829
Kremer L, Douglas JD, Baulard AR, Morehouse C, Guy MR, Alland D, Dover LG, Lakey JH, Jacobs WR Jr, Brennan PJ, Minnikin DE, Besra GS (2000) Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis. J Biol Chem 275:16857–16864
Kremer L, Dover LG, Carrere S, Nampoothiri KM, Lesjean S, Brown AK, Brennan PJ, Minnikin DE, Locht C, Besra GS (2002) Mycolic acid biosynthesis and enzymic characterization of the beta-ketoacyl-ACP synthase A-condensing enzyme from Mycobacterium tuberculosis. Biochem J 364:423–430
Kremer L, Dover LG, Morbidoni HR, Vilcheze C, Maughan WN, Baulard A, Tu SC, Honore N, Deretic V, Sacchettini JC, Locht C, Jacobs WR Jr, Besra GS (2003) Inhibition of InhA activity, but not KasA activity, induces formation of a KasA-containing complex in mycobacteria. J Biol Chem 278:20547–22055
La Rosa V, Poce G, Canseco JO, Buroni S, Pasca MR, Biava M, Raju RM, Porretta GC, Alfonso S, Battilocchio C, Javid B, Sorrentino F, Ioerger TR, Sacchettini JC, Manetti F, Botta M, De Logu A, Rubin EJ, De Rossi E (2012) MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212. Antimicrob Agents Chemother 56:324–331
Laneelle MA, Laneelle G (1970) Structure of mycolic acids and an intermediate in the biosynthesis of dicarboxylic mycolic acids. Eur J Biochem 12:296–300
Laneelle MA, Launay A, Spina L, Marrakchi H, Laval F, Eynard N, Lemassu A, Tropis M, Daffe M, Etienne G (2012) A novel mycolic acid species defines two novel genera of the Actinobacteria, Hoyosella and Amycolicicoccus. Microbiology 158:843–855
Laneelle MA, Eynard N, Spina L, Lemassu A, Laval F, Huc E, Etienne G, Marrakchi H, Daffe M (2013) Structural elucidation and genomic scrutiny of the C60–C100 mycolic acids of Segniliparus rotundus. Microbiology 159:191–203
Laneelle MA, Nigou J, Daffe M (2015) Lipid and lipoarabinomannan isolation and characterization. Methods Mol Biol 1285:77–103
Laval F, Laneelle MA, Deon C, Monsarrat B, Daffe M (2001) Accurate molecular mass determination of mycolic acids by MALDI-TOF mass spectrometry. Anal Chem 73:4537–4544
Laval F, Haites R, Movahedzadeh F, Lemassu A, Wong CY, Stoker N, Billman-Jacobe H, Daffe M (2008) Investigating the function of the putative mycolic acid methyltransferase UmaA: divergence between the Mycobacterium smegmatis and Mycobacterium tuberculosis proteins. J Biol Chem 283:1419–1427
Layre E, Collmann A, Bastian M, Mariotti S, Czaplicki J, Prandi J, Mori L, Stenger S, De Libero G, Puzo G, Gilleron M (2009) Mycolic acids constitute a scaffold for mycobacterial lipid antigens stimulating CD1-restricted T cells. Chem Biol 16:82–92
Le NH, Molle V, Eynard N, Miras M, Stella A, Bardou F, Galandrin S, Guillet V, Andre-Leroux G, Bellinzoni M, Alzari P, Mourey L, Burlet-Schiltz O, Daffe M, Marrakchi H (2016) Ser/Thr phosphorylation regulates the Fatty Acyl-AMP Ligase activity of FadD32, an essential enzyme in mycolic acid biosynthesis. J Biol Chem 291:22793–22805
Lea-Smith DJ, Pyke JS, Tull D, McConville MJ, Coppel RL, Crellin PK (2007) The reductase that catalyzes mycolic motif synthesis is required for efficient attachment of mycolic acids to arabinogalactan. J Biol Chem 282:11000–11008
Lederer E (1969) Some problems concerning biological C-alkylation reactions and phytosterol biosynthesis. Q Rev Chem Soc 23:453–481
Leger M, Gavalda S, Guillet V, van der Rest B, Slama N, Montrozier H, Mourey L, Quemard A, Daffe M, Marrakchi H (2009) The dual function of the Mycobacterium tuberculosis FadD32 required for mycolic acid biosynthesis. Chem Biol 16:510–519
Li W, Upadhyay A, Fontes FL, North EJ, Wang Y, Crans DC, Grzegorzewicz AE, Jones V, Franzblau SG, Lee RE, Crick DC, Jackson M (2014) Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosis. Antimicrob Agents Chemother 58:6413–6423
Li W, Gu S, Fleming J, Bi L (2015) Crystal structure of FadD32, an enzyme essential for mycolic acid biosynthesis in mycobacteria. Sci Rep 5:15493
Li W, Obregon-Henao A, Wallach JB, North EJ, Lee RE, Gonzalez-Juarrero M, Schnappinger D, Jackson M (2016) Therapeutic potential of the Mycobacterium tuberculosis mycolic acid transporter, MmpL3. Antimicrob Agents Chemother 60:5198–5207
Liu J, Barry CE 3rd, Besra GS, Nikaido H (1996) Mycolic acid structure determines the fluidity of the mycobacterial cell wall. J Biol Chem 271:29545–29551
Mann KM, Pride A, Flentie K, Kimmey J, Weiss L, Stallings C (2016) Analysis of the contribution of MTP and the predicted Flp pilus genes to Mycobacterium tuberculosis pathogenesis. Microbiology 162:1784–1796
Marchand CH, Salmeron C, Bou Raad R, Meniche X, Chami M, Masi M, Blanot D, Daffe M, Tropis M, Huc E, Le Marechal P, Decottignies P, Bayan N (2012) Biochemical disclosure of the mycolate outer membrane of Corynebacterium glutamicum. J Bacteriol 194:587–597
Marrakchi H, Laneelle G, Quemard A (2000) InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II. Microbiology 146:289–296
Marrakchi H, Choi KH, Rock CO (2002) A new mechanism for anaerobic unsaturated fatty acid formation in Streptococcus pneumoniae. J Biol Chem 277:44809–44816
Marrakchi H, Laneelle MA, Daffe M (2014) Mycolic acids: structures, biosynthesis, and beyond. Chem Biol 21:67–85
Mdluli K, Sherman DR, Hickey MJ, Kreiswirth BN, Morris S, Stover CK, Barry CE 3rd (1996) Biochemical and genetic data suggest that InhA is not the primary target for activated isoniazid in Mycobacterium tuberculosis. J Infect Dis 174:1085–1090
Mitchison DA (1998) Basic concepts in the chemotherapy of tuberculosis. In: Gangadharam PRJ, Jenkins PA (ed) Mycobacteria: II chemotherapy. Chapman & Hall Medical Microbiology Series, Springer US, pp 15–43
Molle V, Kremer L (2010) Division and cell envelope regulation by Ser/Thr phosphorylation: Mycobacterium shows the way. Mol Microbiol 75:1064–1077
Mondino S, Gago G, Gramajo H (2013) Transcriptional regulation of fatty acid biosynthesis in mycobacteria. Mol Microbiol 89:372–387
Moody DB, Reinhold BB, Guy MR, Beckman EM, Frederique DE, Furlong ST, Ye S, Reinhold VN, Sieling PA, Modlin RL, Besra GS, Porcelli SA (1997) Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 278:283–286
Moody DB, Guy MR, Grant E, Cheng TY, Brenner MB, Besra GS, Porcelli SA (2000) CD1b-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection. J Exp Med 192:965–976
Nikiforov PO, Surade S, et al (2016) A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters. Org Biomol Chem 14(7):2318–2326
North EJ, Jackson M, Lee RE (2014) New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics. Curr Pharm Des 20:4357–4378
Odriozola JM, Ramos JA, Bloch K (1977) Fatty acid synthetase activity in Mycobacterium smegmatis. Characterization of the acyl carrier protein-dependent elongating system. Biochim Biophys Acta 488:207–217
Oh TJ, Daniel J, Kim HJ, Sirakova TD, Kolattukudy PE (2006) Identification and characterization of Rv3281 as a novel subunit of a biotin-dependent acyl-CoA Carboxylase in Mycobacterium tuberculosis H37Rv. J Biol Chem 281:3899–3908
Ojha A, Anand M, Bhatt A, Kremer L, Jacobs WR Jr, Hatfull GF (2005) GroEL1: a dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria. Cell 123:861–873
Ojha AK, Baughn AD, Sambandan D, Hsu T, Trivelli X, Guerardel Y, Alahari A, Kremer L, Jacobs WR Jr, Hatfull GF (2008) Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol Microbiol 69:164–174
Ojha AK, Trivelli X, Guerardel Y, Kremer L, Hatfull GF (2010) Enzymatic hydrolysis of trehalose dimycolate releases free mycolic acids during mycobacterial growth in biofilms. J Biol Chem 285:17380–17389
Pacheco SA, Hsu FF, Powers KM, Purdy GE (2013) MmpL11 protein transports mycolic acid-containing lipids to the mycobacterial cell wall and contributes to biofilm formation in Mycobacterium smegmatis. J Biol Chem 288:24213–24222
Parish T, Roberts G, Laval F, Schaeffer M, Daffe M, Duncan K (2007) Functional complementation of the essential gene fabG1 of Mycobacterium tuberculosis by Mycobacterium smegmatis fabG, but not Escherichia coli fabG. J Bacteriol 189:3721–3728
Payne K, Sun Q, Sacchettini J, Hatfull GF (2009) Mycobacteriophage Lysin B is a novel mycolylarabinogalactan esterase. Mol Microbiol 73:367–381
Peyron P, Vaubourgeix J, Poquet Y, Levillain F, Botanch C, Bardou F, Daffe M, Emile JF, Marchou B, Cardona PJ, de Chastellier C, Altare F (2008) Foamy macrophages from tuberculous patients’ granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog 4:e1000204
Phetsuksiri B, Jackson M, Scherman H, McNeil M, Besra GS, Baulard AR, Slayden RA, DeBarber AE, Barry CE 3rd, Baird MS, Crick DC, Brennan PJ (2003) Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis. J Biol Chem 278:53123–53130
Portevin D, De Sousa-D’Auria C, Houssin C, Grimaldi C, Chami M, Daffe M, Guilhot C (2004) A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms. Proc Natl Acad Sci U S A 101:314–319
Portevin D, de Sousa-D’Auria C, Montrozier H, Houssin C, Stella A, Laneelle MA, Bardou F, Guilhot C, Daffe M (2005) The acyl-AMP ligase FadD32 and AccD4-containing acyl-CoA carboxylase are required for the synthesis of mycolic acids and essential for mycobacterial growth: identification of the carboxylation product and determination of the acyl-CoA carboxylase components. J Biol Chem 280:8862–8874
Puech V, Guilhot C, Perez E, Tropis M, Armitige LY, Gicquel B, Daffe M (2002) Evidence for a partial redundancy of the fibronectin-binding proteins for the transfer of mycoloyl residues onto the cell wall arabinogalactan termini of Mycobacterium tuberculosis. Mol Microbiol 44:1109–1122
Purwantini E, Mukhopadhyay B (2013) Rv0132c of Mycobacterium tuberculosis encodes a coenzyme F420-dependent hydroxymycolic acid dehydrogenase. PLoS One 8:e81985
Queiroz A, Medina-Cleghorn D, Marjanovic O, Nomura DK, Riley LW (2015) Comparative metabolic profiling of mce1 operon mutant vs wild-type Mycobacterium tuberculosis strains. Pathog Dis 73:ftv066
Quemard A (2016) New insights into the mycolate-containing compound biosynthesis and transport in mycobacteria. Trends Microbiol 24:725–738
Quemard A, Lacave C, Laneelle G (1991) Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum. Antimicrob Agents Chemother 35:1035–1039
Quemard A, Sacchettini JC, Dessen A, Vilcheze C, Bittman R, Jacobs WR Jr, Blanchard JS (1995) Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry (Mosc) 34:8235–8241
Quémard A, Dessen A, Sugantino M, Jacobs WR Jr, Sacchettini JC, Blanchard JS (1996) Binding of catalase-peroxidase-activated isoniazid to wild-type and mutant Mycobacterium tuberculosis enoyl-ACP reductases. J Am Chem Soc 118:1561–1562
Qureshi N, Sathyamoorthy N, Takayama K (1984) Biosynthesis of C30 to C56 fatty acids by an extract of Mycobacterium tuberculosis H37Ra. J Bacteriol 157:46–52
Rafidinarivo E, Prome JC, Levy-Frebault V (1985) New kinds of unsaturated mycolic acids from Mycobacterium fallax sp. nov. Chem Phys Lipids 36:215–228
Ramesh R, Shingare RD, Kumar V, Anand ABS, Veeraraghavan S, Viswanadha S, Ummanni R, Gokhale R, Srinivasa Reddy D (2016) Repurposing of a drug scaffold: identification of novel sila analogues of rimonabant as potent antitubercular agents. Eur J Med Chem 122:723–730
Rao V, Gao F, Chen B, Jacobs WR Jr, Glickman MS (2006) Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence. J Clin Invest 116:1660–1667
Rehm HJ, Reiff I (1981) Mechanisms and occurence of microbial oxidation of long-chain alkanes. Adv Biochem Eng 19:175–215
Rock CO, Cronan JE (1996) Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesis. Biochim Biophys Acta 1302:1–16
Rombouts Y, Brust B, Ojha AK, Maes E, Coddeville B, Elass-Rochard E, Kremer L, Guerardel Y (2012) Exposure of mycobacteria to cell wall-inhibitory drugs decreases production of arabinoglycerolipid related to Mycolyl-arabinogalactan-peptidoglycan metabolism. J Biol Chem 287:11060–11069
Rozwarski DA, Grant GA, Barton DH, Jacobs WR Jr, Sacchettini JC (1998) Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 279:98–102
Sacco E, Covarrubias AS, O’Hare HM, Carroll P, Eynard N, Jones TA, Parish T, Daffe M, Backbro K, Quemard A (2007) The missing piece of the type II fatty acid synthase system from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 104:14628–14633
Salzman V, Mondino S, Sala C, Cole ST, Gago G, Gramajo H (2010) Transcriptional regulation of lipid homeostasis in mycobacteria. Mol Microbiol 78:64–77
Sambandan D, Dao DN, Weinrick BC, Vilcheze C, Gurcha SS, Ojha A, Kremer L, Besra GS, Hatfull GF, Jacobs WR Jr (2013) Keto-mycolic acid-dependent pellicle formation confers tolerance to drug-sensitive Mycobacterium tuberculosis. MBio 4:e00222–13
Sani M, Houben EN, Geurtsen J, Pierson J, de Punder K, van Zon M, Wever B, Piersma SR, Jimenez CR, Daffe M, Appelmelk BJ, Bitter W, van der Wel N, Peters PJ (2010) Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins. PLoS Pathog 6:e1000794
Schaeffer ML, Agnihotri G, Volker C, Kallender H, Brennan PJ, Lonsdale JT (2001) Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB. J Biol Chem 276:47029–47037
Singh A, Varela C, Bhatt K, Veerapen N, Lee OY, Wu HH, Besra GS, Minnikin DE, Fujiwara N, Teramoto K, Bhatt A (2016) Identification of a desaturase involved in mycolic acid biosynthesis in Mycobacterium smegmatis. PLoS One 11:e0164253
Sinha BK (1983) Enzymatic activation of hydrazine derivatives. A spin-trapping study. J Biol Chem 258:796–801
Slama N, Leiba J, Eynard N, Daffe M, Kremer L, Quemard A, Molle V (2011) Negative regulation by Ser/Thr phosphorylation of HadAB and HadBC dehydratases from Mycobacterium tuberculosis type II fatty acid synthase system. Biochem Biophys Res Commun 412:401–406
Slama N, Jamet S, Frigui W, Pawlik A, Bottai D, Laval F, Constant P, Lemassu A, Cam K, Daffe M, Brosch R, Eynard N, Quemard A (2016) The changes in mycolic acid structures caused by hadC mutation have a dramatic effect on the virulence of Mycobacterium tuberculosis. Mol Microbiol 99:794–807
Stanley SA, Kawate T, Iwase N, Shimizu M, Clatworthy AE, Kazyanskaya E, Sacchettini JC, Ioerger TR, Siddiqi NA, Minami S, Aquadro JA, Schmidt Grant S, Rubin EJ, Hung DT (2013) Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32. Proc Natl Acad Sci U S A 110:11565–11570
Stec J, Onajole OK, Lun S, Guo H, Merenbloom B, Vistoli G, Bishai WR, Kozikowski AP (2016) Indole-2-carboxamide-based MmpL3 inhibitors show exceptional antitubercular activity in an animal model of tuberculosis infection. J Med Chem 59:6232–6247
Tahlan K, Wilson R, Kastrinsky DB, Arora K, Nair V, Fischer E, Barnes SW, Walker JR, Alland D, Barry CE 3rd, Boshoff HI (2012) SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis. Antimicrob Agents Chemother 56:1797–1809
Takayama K, Qureshi N (1978) Isolation and characterization of the monounsaturated long chain fatty acids of Mycobacterium tuberculosis. Lipids 13:575–579
Takayama K, Wang L, David HL (1972) Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2:29–35
Takayama K, Wang C, Besra GS (2005) Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin Microbiol Rev 18:81–101
Tang X, Deng W, Xie J (2012) Novel insights into Mycobacterium antigen Ag85 biology and implications in countermeasures for M. tuberculosis. Crit Rev Eukaryot Gene Expr 22:179–187
Tarnok I, Rohrscheidt E (1976) Biochemical background of some enzymatic tests used for the differentiation of mycobacteria. Tubercle 57:145–150
Tomiyasu I, Yano I (1984) Separation and analysis of novel polyunsaturated mycolic acids from a psychrophilic, acid-fast bacterium, Gordona aurantiaca. Eur J Biochem 139:173–180
Toriyama S, Izaizumi S, Tomiyasu I, Masui M, Yano I (1982) Incorporation of 18O into long-chain secondary alkohols derived from ester mycolic acids in Mycobacterium phlei. Biochim Biophys Acta 712:427–429
Trivedi OA, Arora P, Sridharan V, Tickoo R, Mohanty D, Gokhale RS (2004) Enzymic activation and transfer of fatty acids as acyl-adenylates in mycobacteria. Nature 428:441–445
Uchida Y, Casali N, White A, Morici L, Kendall LV, Riley LW (2007) Accelerated immunopathological response of mice infected with Mycobacterium tuberculosis disrupted in the mce1 operon negative transcriptional regulator. Cell Microbiol 9:1275–1283
Vander Beken S, Al Dulayymi JR, et al (2011) Molecular structure of the Mycobacterium tuberculosis virulence factor, mycolic acid, determines the elicited inflammatory pattern. Eur J Immunol 41(2):450–460
Varela C, Rittmann D, Singh A, Krumbach K, Bhatt K, Eggeling L, Besra GS, Bhatt A (2012) MmpL genes are associated with mycolic acid metabolism in mycobacteria and corynebacteria. Chem Biol 19:498–506
Vergne I, Daffe M (1998) Interaction of mycobacterial glycolipids with host cells. Front Biosci 3:d865–d876
Verschoor JA, Baird MS, Grooten J (2012) Towards understanding the functional diversity of cell wall mycolic acids of Mycobacterium tuberculosis. Prog Lipid Res 51:325–339
Veyron-Churlet R, Guerrini O, Mourey L, Daffe M, Zerbib D (2004) Protein-protein interactions within the Fatty Acid Synthase-II system of Mycobacterium tuberculosis are essential for mycobacterial viability. Mol Microbiol 54:1161–1172
Veyron-Churlet R, Bigot S, Guerrini O, Verdoux S, Malaga W, Daffe M, Zerbib D (2005) The biosynthesis of mycolic acids in Mycobacterium tuberculosis relies on multiple specialized elongation complexes interconnected by specific protein-protein interactions. J Mol Biol 353:847–858
Vilcheze C, Morbidoni HR, Weisbrod TR, Iwamoto H, Kuo M, Sacchettini JC, Jacobs WR Jr (2000) Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis. J Bacteriol 182:4059–4067
Vilcheze C, Molle V, Carrere-Kremer S, Leiba J, Mourey L, Shenai S, Baronian G, Tufariello J, Hartman T, Veyron-Churlet R, Trivelli X, Tiwari S, Weinrick B, Alland D, Guerardel Y, Jacobs WR Jr, Kremer L (2014) Phosphorylation of KasB regulates virulence and acid-fastness in Mycobacterium tuberculosis. PLoS Pathog 10:e1004115
Villeneuve M, Kawai M, Kanashima H, Watanabe M, Minnikin DE, Nakahara H (2005) Temperature dependence of the Langmuir monolayer packing of mycolic acids from Mycobacterium tuberculosis. Biochim Biophys Acta 1715:71–80
Villeneuve M, Kawai M, Watanabe M, Aoyagi Y, Hitotsuyanagi Y, Takeya K, Gouda H, Hirono S, Minnikin DE, Nakahara H (2007) Conformational behavior of oxygenated mycobacterial mycolic acids from Mycobacterium bovis BCG. Biochim Biophys Acta 1768:1717–1726
Villeneuve M, Kawai M, Horiuchi K, Watanabe M, Aoyagi Y, Hitotsuyanagi Y, Takeya K, Gouda H, Hirono S, Minnikin DE (2013) Conformational folding of mycobacterial methoxy- and ketomycolic acids facilitated by alpha-methyl trans-cyclopropane groups rather than cis-cyclopropane units. Microbiology 159:2405–2415
Wang F, Langley R, Gulten G, Dover LG, Besra GS, Jacobs WR Jr, Sacchettini JC (2007) Mechanism of thioamide drug action against tuberculosis and leprosy. J Exp Med 204:73–78
Wang XM, Lu C, Soetaert K, S’Heeren C, Peirs P, Laneelle MA, Lefevre P, Bifani P, Content J, Daffe M, Huygen K, De Bruyn J, Wattiez R (2011) Biochemical and immunological characterization of a cpn60.1 knockout mutant of Mycobacterium bovis BCG. Microbiology 157:1205–1219
Warrier T, Tropis M, Werngren J, Diehl A, Gengenbacher M, Schlegel B, Schade M, Oschkinat H, Daffe M, Hoffner S, Eddine AN, Kaufmann SH (2012) Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesis. Antimicrob Agents Chemother 56:1735–1743
Watanabe M, Aoyagi Y, Ridell M, Minnikin DE (2001) Separation and characterization of individual mycolic acids in representative mycobacteria. Microbiology 147:1825–1837
Wehenkel A, Bellinzoni M, Grana M, Duran R, Villarino A, Fernandez P, Andre-Leroux G, England P, Takiff H, Cervenansky C, Cole ST, Alzari PM (2008) Mycobacterial Ser/Thr protein kinases and phosphatases: physiological roles and therapeutic potential. Biochim Biophys Acta 1784:193–202
Wilson R, Kumar P, Parashar V, Vilcheze C, Veyron-Churlet R, Freundlich JS, Barnes SW, Walker JR, Szymonifka MJ, Marchiano E, Shenai S, Colangeli R, Jacobs WR Jr, Neiditch MB, Kremer L, Alland D (2013) Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis. Nat Chem Biol 9:499–506
Winder FG (1982) Mode of action of the antimycobacterial agents and associated aspects of the molecular biology of the mycobacteria. In: Ratledge C, Stanford J (eds) The biology of the mycobacteria. Academic, London, pp 354–438
Wong MY, Gray GR (1979) Structures of the homologous series of monoalkene mycolic acids from Mycobacterium smegmatis. J Biol Chem 254:5741–5744
Yuan Y, Barry CE (1996) A common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 93:12828–12833
Yuan Y, Mead D, Schroeder BG, Zhu Y, Barry CE 3rd (1998) The biosynthesis of mycolic acids in Mycobacterium tuberculosis. Enzymatic methyl(ene) transfer to acyl carrier protein bound meromycolic acid in vitro. J Biol Chem 273:21282–21290
Zhang Y, Heym B, Allen B, Young D, Cole S (1992) The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:591–593
Zuber B, Chami M, Houssin C, Dubochet J, Griffiths G, Daffe M (2008) Direct visualization of the outer membrane of mycobacteria and corynebacteria in their native state. J Bacteriol 190:5672–5680
Acknowledgments
The authors are grateful to their colleagues for fruitful collaborations and discussions, and for sharing unpublished material. We acknowledge funding from the European Union (NM4TB, grant LSHP-CT-2005-018923; TB-Drug grant LSHP-CT-2006-037217; SysteMTb HEALTH-2009-2.1.2-1 241587), the Agence Nationale de la Recherche (XPKS-MYCO, grant 09-BLAN-0298-03; FASMY, grant ANR-14-CE16-0012), the Région Midi-Pyrénées (MYCA, FEDER grant 34249), the France-Argentina ECOS-MINCyT cooperation program (grant A11B04) and the “Vaincre la Mucoviscidose” association (IC0716, France).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Daffé, M., Quémard, A., Marrakchi, H. (2019). Mycolic Acids: From Chemistry to Biology. In: Geiger, O. (eds) Biogenesis of Fatty Acids, Lipids and Membranes. Handbook of Hydrocarbon and Lipid Microbiology . Springer, Cham. https://doi.org/10.1007/978-3-319-50430-8_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-50430-8_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-50429-2
Online ISBN: 978-3-319-50430-8
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences